Monday, January 17, 2022

The Europeans showed chloroquine worked against SARS-1 in 2004. CDC confirmed their findings the next year

In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine rights and content


We report on chloroquine, a 4-amino-quinoline, as an effective inhibitor of the replication of the severe acute respiratory syndrome coronavirus (SARS-CoV) in vitro. Chloroquine is a clinically approved drug effective against malaria. We tested chloroquine phosphate for its antiviral potential against SARS-CoV-induced cytopathicity in Vero E6 cell culture. Results indicate that the IC50 of chloroquine for antiviral activity (8.8 ± 1.2 μM) was significantly lower than its cytostatic activity; CC50 (261.3 ± 14.5 μM), yielding a selectivity index of 30. The IC50 of chloroquine for inhibition of SARS-CoV in vitro approximates the plasma concentrations of chloroquine reached during treatment of acute malaria. Addition of chloroquine to infected cultures could be delayed for up to 5 h postinfection, without an important drop in antiviral activity. Chloroquine, an old antimalarial drug, may be considered for immediate use in the prevention and treatment of SARS-CoV infections.


Anonymous said...

BOMBSHELL: FDA Allows Whistleblower Testimony, Yes, COVID VaXxs Are Killing and Harming People!

'Fauci and CDC Director Rochelle Walensky Lie Under Oath.'

Anonymous said...

"We Failed": Danish Newspaper Apologizes For Publishing Official COVID Narratives Without Questioning Them.

Anonymous said...

‘Waste of Time’ to Keep Vaccinating People: Ex-Head of UK Vaccine Taskforce.